Natural history of non-functioning pituitary microadenomas: results from the UK non-functioning pituitary adenoma consortium
dc.contributor.author | Hamblin, R | |
dc.contributor.author | Fountas, A | |
dc.contributor.author | Lithgow, K | |
dc.contributor.author | Loughrey, PB | |
dc.contributor.author | Bonanos, E | |
dc.contributor.author | Shinwari, SK | |
dc.contributor.author | Mitchell, K | |
dc.contributor.author | Shah, S | |
dc.contributor.author | Grixti, L | |
dc.contributor.author | Matheou, M | |
dc.contributor.author | Isand, K | |
dc.contributor.author | McLaren, DS | |
dc.contributor.author | Surya, A | |
dc.contributor.author | Ullah, HZ | |
dc.contributor.author | Klaucane, K | |
dc.contributor.author | Jayasuriya, A | |
dc.contributor.author | Bhatti, S | |
dc.contributor.author | Mavilakandy, A | |
dc.contributor.author | Ashan, M | |
dc.contributor.author | Mathew, S | |
dc.contributor.author | Hussein, Z | |
dc.contributor.author | Jansz, T | |
dc.contributor.author | Wunna, W | |
dc.contributor.author | MacFarlane, J | |
dc.contributor.author | Ayuk, J | |
dc.contributor.author | Abraham, P | |
dc.contributor.author | Drake, WM | |
dc.contributor.author | Gurnell, M | |
dc.contributor.author | Brooke, A | |
dc.contributor.author | Baldeweg, SE | |
dc.contributor.author | Sam, AH | |
dc.contributor.author | Martin, N | |
dc.contributor.author | Higham, C | |
dc.contributor.author | Reddy, N | |
dc.contributor.author | Levy, MJ | |
dc.contributor.author | Ahluwalia, R | |
dc.contributor.author | Newell-Price, J | |
dc.contributor.author | Vamvakopoulos, J | |
dc.contributor.author | Krishnan, A | |
dc.contributor.author | Lansdown, A | |
dc.contributor.author | Murray, RD | |
dc.contributor.author | Pal, A | |
dc.contributor.author | Bradley, K | |
dc.contributor.author | Mamoojee, Y | |
dc.contributor.author | Purewal, T | |
dc.contributor.author | Panicker, J | |
dc.contributor.author | Freel, EM | |
dc.contributor.author | Hasan, F | |
dc.contributor.author | Kumar, M | |
dc.contributor.author | Jose, B | |
dc.contributor.author | Hunter, SJ | |
dc.contributor.author | Karavitaki, N | |
dc.date.accessioned | 2024-04-09T13:42:39Z | |
dc.date.available | 2024-04-09T13:42:39Z | |
dc.date.issued | 2023-07 | |
dc.description.abstract | Objective: The optimal approach to the surveillance of non-functioning pituitary microadenomas (micro-NFPAs) is not clearly established. Our aim was to generate evidence on the natural history of micro-NFPAs to support patient care. Design: Multi-centre, retrospective, cohort study involving 23 endocrine departments (UK NFPA consortium). Methods: Clinical, imaging, and hormonal data of micro-NFPA cases between January, 1, 2008 and December, 21, 2021 were analysed. Results: Data for 459 patients were retrieved [median age at detection 44 years (IQR 31-57)-152 males/307 females]. Four hundred and nineteen patients had more than two magnetic resonance imagings (MRIs) [median imaging monitoring 3.5 years (IQR 1.71-6.1)]. One case developed apoplexy. Cumulative probability of micro-NFPA growth was 7.8% (95% CI, 4.9%-8.1%) and 14.5% (95% CI, 10.2%-18.8%) at 3 and 5 years, respectively, and of reduction 14.1% (95% CI, 10.4%-17.8%) and 21.3% (95% CI, 16.4%-26.2%) at 3 and 5 years, respectively. Median tumour enlargement was 2 mm (IQR 1-3) and 49% of micro-NFPAs that grew became macroadenomas (nearly all >5 mm at detection). Eight (1.9%) patients received surgery (only one had visual compromise with surgery required >3 years after micro-NFPA detection). Sex, age, and size at baseline were not predictors of enlargement/reduction. At the time of detection, 7.2%, 1.7%, and 1.5% patients had secondary hypogonadism, hypothyroidism, and hypoadrenalism, respectively. Two (0.6%) developed hypopituitarism during follow-up (after progression to macroadenoma). Conclusions: Probability of micro-NFPA growth is low, and the development of new hypopituitarism is rare. Delaying the first follow-up MRI to 3 years and avoiding hormonal re-evaluation in the absence of tumour growth or clinical manifestations is a safe approach for micro-NFPA surveillance. | |
dc.identifier.citation | Eur J Endocrinol . 2023 Jul 20;189(1):87-95 | |
dc.identifier.doi | 10.1093/ejendo/lvad070. | |
dc.identifier.pmid | 37345849 | |
dc.identifier.scopus | Kumar, Mohit - Author details - Scopus Preview | |
dc.identifier.uri | https://wwl.dspace-express.com/handle/20.500.13063/104 | |
dc.language.iso | en | |
dc.publisher | Oxford Academic | |
dc.title | Natural history of non-functioning pituitary microadenomas: results from the UK non-functioning pituitary adenoma consortium | |
dc.type | Article |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.98 KB
- Format:
- Item-specific license agreed to upon submission
- Description: